Autohypnosis and Cancerology

Groupe Hospitalier Mutualiste de Grenoble

Status: Completed

Conditions: Breast Cancer; Colorectal Cancer

Treatments: Other: Autohypnosis learning

Study type: Interventional

Funder types: Other

Identifiers

NCT03429296

2017/12-SBO-GHMG

Details and patient eligibility

About

Therapeutical hypnosis is proven to be an effective medical support to chemotherapy: it was shown that it can reduce the pain, anxiety, fatigue felt by the patient.

Yet, hypnosis requires the presence of an hypnotherapist, which is why auto-hypnosis could be an efficient alternative to handle the side effects of chemotherapy.

In this study, colorectal cancer and breast cancer patients are either taught auto-hypnosis or are taken in standard care for their chemotherapy.

The life quality score (QLQC30) assessed during and after chemotherapies will determine if auto-hypnosis is a good medical support in chemotherapies' adverse effects management.

The proven benefices of auto-hypnosis in the handling of the side effects of chemotherapies could improve the quality of life of cancer affected patients.

Enrollment: 120 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age superior or equal to 18 years old

• Colorectal or breast cancer history, treated by surgery and that should undergo an adjuvant chemotherapy

  • In the case of breast cancer, adjuvant chemotherapy must involve anthracyclines

• ECOG performance score < 3

• Patient must be affiliated or beneficiary of social security or any similar regime

Exclusion criteria

• Patients already included in another interventional clinical research protocol
• Patients unable to proceed to hypnosis treatment due to their speech limitations (poor comprehension and expression of french, deafness, mental illness)
• Patients protected by French law from clinical inclusion ( pregnant, in labour, breastfeeding, legally protected, under judiciary or administrative liberty deprivation...)

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

120 participants in 2 patient groups

Autohypnosis learning

Experimental group

Description:

In this arm, patients are taught autohypnosis during sessions in groups of 3 to 6 with a qualified hypnotherapist. Sessions are set every two weeks, for a total of 6 sessions. Individual sessions are possible for patients who missed a session.

Treatment:

Other: Autohypnosis learning

Standard of care

No Intervention group

Description:

In this arm, patients are not taught autohypnosis and are treated according to standard of care.